Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness of screening forHLA-A*31:01prior to initiation of carbamazepine in epilepsy
Authors
Keywords
-
Journal
EPILEPSIA
Volume 56, Issue 4, Pages 556-563
Publisher
Wiley
Online
2015-02-26
DOI
10.1111/epi.12937
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
- (2014) Ursula Amstutz et al. EPILEPSIA
- Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Carbamazepine Dosing
- (2013) S G Leckband et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand
- (2013) Waranya Rattanavipapong et al. EPILEPSIA
- Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis
- (2013) Peggy Sekula et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis
- (2013) E Genin et al. PHARMACOGENOMICS JOURNAL
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
- (2013) Don Husereau et al. VALUE IN HEALTH
- HLA Genotype and Carbamazepine-Induced Cutaneous Adverse Drug Reactions: A Systematic Review
- (2012) V L Yip et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy
- (2012) Eugen Trinka et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Cost-effectiveness of HLA-B*1502 genotyping in adult patients with newly diagnosed epilepsy in Singapore
- (2012) D. Dong et al. NEUROLOGY
- Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions
- (2012) Mark McCormack et al. PHARMACOGENOMICS
- Deriving Input Parameters for Cost-Effectiveness Modeling: Taxonomy of Data Types and Approaches to Their Statistical Synthesis
- (2012) Pedro Saramago et al. VALUE IN HEALTH
- Phenotype Standardization for Immune-Mediated Drug-Induced Skin Injury
- (2011) M Pirmohamed et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validation of the EQ-5D questionnaire in burn injured adults
- (2009) Caisa Öster et al. BURNS
- Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids
- (2009) CD Poole et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- The Impact of Severe Sepsis on Health-Related Quality of Life: A Long-Term Follow-Up Study
- (2008) José G. M. Hofhuis et al. ANESTHESIA AND ANALGESIA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search